Gregory P. Donoho
Impact in
- Molecular Biology top 10%
- CRISPR and Genetic Engineering
- DNA Repair Mechanisms
- Pluripotent Stem Cells Research
- PI3K/AKT/mTOR signaling in cancer
- RNA Interference and Gene Delivery
- Oncology top 10%
- PARP inhibition in cancer therapy
Papers in
-
- DNA Repair Mechanisms 9
- PI3K/AKT/mTOR signaling in cancer 6
- CRISPR and Genetic Engineering 3
- Oncology 19
- PARP inhibition in cancer therapy 5
- Colorectal Cancer Treatments and Studies 3
- Cancer Cells and Metastasis 3
- Lung Cancer Research Studies 3
- Co-authors
- Paul Berg (1 shared paper)Maria Jasin (1 shared paper)Paul Hasty (2 shared papers)Masami Morimatsu (1 shared paper)Janusz Steczko (2 shared papers)Bernard Axelrod (2 shared papers)Max Gassmann (1 shared paper)P Berg (1 shared paper)
- Journals
- Cancer Research (7 papers)Molecular Cancer Therapeutics (5 papers)Clinical Cancer Research (4 papers)Investigational New Drugs (1 paper)Journal of Thoracic Oncology (1 paper)
- Partner nations
- United StatesSouth KoreaGermany
In The Last Decade
Gregory P. Donoho
32 papers receiving 985 citations
Peers
Comparison fields: 5 of 82
- Molecular Biology 698
- Oncology 236
- Cancer Research 128
- Genetics 168
- Cell Biology 74
Countries citing papers authored by Gregory P. Donoho
This map shows the geographic impact of Gregory P. Donoho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory P. Donoho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory P. Donoho more than expected).
Fields of papers citing papers by Gregory P. Donoho
This network shows the impact of papers produced by Gregory P. Donoho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory P. Donoho. The network helps show where Gregory P. Donoho may publish in the future.
Co-authors
The 25 scholars most cited alongside Gregory P. Donoho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 145 | |
| 2 | Cells deleted for Brca2 COOH terminus exhibit hypersensitivity to gamma-radiation and premature senescence. | 1998 | 97 |
| 3 | 2003 | 83 | |
| 4 | 1992 | 76 | |
| 5 | 1995 | 72 | |
| 6 | 1991 | 68 | |
| 7 | 2016 | 62 | |
| 8 | 2013 | 53 | |
| 9 | 2003 | 40 | |
| 10 | 2017 | 39 | |
| 11 | 2021 | 37 | |
| 12 | 2022 | 31 | |
| 13 | 2015 | 29 | |
| 14 | 2015 | 27 | |
| 15 | 2013 | 24 | |
| 16 | 2018 | 19 | |
| 17 | 2015 | 19 | |
| 18 | 2012 | 14 | |
| 19 | 2020 | 13 | |
| 20 | 2020 | 13 |
About Gregory P. Donoho
Gregory P. Donoho is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Genetics, having authored 32 papers that have together received 1000 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (9 papers), Cancer Genomics and Diagnostics (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), PARP inhibition in cancer therapy (5 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Cells and Metastasis (3 papers), CRISPR and Genetic Engineering (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Molecular Biology (698 citations), Oncology (236 citations), Cancer Research (128 citations), Genetics (168 citations) and Cell Biology (74 citations). Gregory P. Donoho has collaborated with scholars based in United States, South Korea and Germany. Frequent co-authors include Paul Berg, Maria Jasin, Paul Hasty, Masami Morimatsu, Janusz Steczko, Bernard Axelrod, Max Gassmann, P Berg, Jack E. Dixon and James C. Clemens. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Clinical Cancer Research, Investigational New Drugs and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.